We have previously reported that in tumorigenic pancreatic ␤-cells, calcitriol exerts a potent antitumorigenic effect by inducing apoptosis, cell growth inhibition, and reduction of solid ␤-cell tumors. Here we have studied the molecular pathways involved in the antineoplastic activity of calcitriol on mouse insulinoma ␤TC 3 cells, mouse insulinoma ␤TC expressing or not expressing the oncogene p53, and ␤TC-tet cells overexpressing or not the antiapoptotic gene Bcl2. Our results indicate that calcitriol-induced apoptosis was dependent on the function of p53 and was associated with a biphasic increase in protein levels of transcription factor nuclear factor-B. 
, also known as calcitriol, acts as an effective regulator of cell growth and differentiation in a number of different cell types, including neoplastic cells (1) . In the past decade several studies have demonstrated the antineoplastic effect of calcitriol on a variety of cancer cell lines, supporting its potential use in the treatment of diverse types of malignancies. Malignant insulinomas are rare endocrine tumors that, in contrast to benign ␤-cell adenomas, are rarely cured by surgery (2) . In addition, malignant insulinomas respond poorly to conventional chemotherapy and treatment with somatostatin (or somatostatin analogs), which are usually effective on other types of endocrine tumors (3, 4) . Moreover, hypoglycemia associated with malignant insulinomas is generally unresponsive to agents that inhibit insulin release, such as diazoxide and certain calcium channel blockers (5) (6) (7) .
We have recently reported that in murine insulinoma ␤TC 3 cells, calcitriol induces growth inhibition and apoptosis (8) .
In the same study we have shown that the cytotoxic effects of calcitriol are limited to ␤-cells with a malignant phenotype (␤TC 3 ), whereas benign human insulinoma cells and normal human islets are unaffected. We have also demonstrated that a short course of treatment with calcitriol reduces significantly the mass of ␤-cell tumors in transgenic RIP1Tag2 mice (8) , a well characterized model of ␤-cell tumorigenesis (9) .
The nuclear vitamin D receptor (nVDR) is a member of the nuclear receptor superfamily that functions as a transcriptional factor and is also present in pancreatic ␤-cells (10) . Calcitriol acts mainly through the so-called genomic pathway, which involves binding of the hormone to its nVDR. The complex calcitriol/nVDR binds to vitamin D-responsive elements in the promoter region of target genes and modulates their transcription. Vitamin D-responsive elements have also been identified in the promoter region of nonclassical vitamin D target genes such as calbindin D (11) , p21 (12) , c-Fos, and TGF␤2 (13) . It has now become evident that calcitriol also induces nontranscriptional responses through the activation of a putative, yet unidentified, membrane receptor (14, 15) . Indeed, calcitriol increases the intracellular levels or activities of several signaling molecules, including protein kinase C (PKC), Raf, MAPK, and Src kinases (16 -18) . We recently reported that in ␤TC 3 cells as well as in human islets, calcitriol activates the MAPK cascade and induces PKC activation via a nongenomic pathway (8) . In ␤TC 3 cells, MAPK activation contributes to calcitriol-induced cytotoxicity, as MAPK kinase (MEK) inhibition with UO126 significantly prevents this effect (8) . We also reported that calcitriol increases caspase-3 activity in ␤TC 3 cells (8) , but no particular efforts were posed in that study to explore in more detail the mechanisms responsible for the antineoplastic effect of calcitriol on these cells.
The aim of this study was to elucidate the molecular pathways involved in the antitumorigenic effects of calcitriol on ␤TC 3 cells. The results show that calcitriol increased the levels of p53 protein and p53 phosphorylated at serine 15, an effect that was prevented by staurosporine, but not by the Abbreviations: cdk, Cyclin-dependent kinase; 1,25-(OH) 2 D 3 , 1,25-dihydroxyvitamin D 3 ; MEK, MAPK kinase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NFB, nuclear factor B; nVDR, nuclear vitamin D receptor; PDTC, pyrrolidine dithiocarbamate; PKC, protein kinase C.
MEK inhibitor (UO126). Moreover, calcitriol-induced ␤TC 3 cell apoptosis was associated to a biphasic increase in the protein levels of nuclear factor-B (NFB), which appears to be a prosurvival cell adaptation. Calcitriol transcriptionally activated several p53-regulated genes involved in the regulation of cell cycle (p21 and G 2 /M-specific cyclin B2), DNA damage (GADD45), and apoptosis (Bak and Bax). Calcitriolinduced insulinoma cell death was significantly reduced in p53 null ␤TC (␤TC p53 Ϫ/Ϫ ) cells and was completely prevented by Bcl-2 overexpression. Finally, exposure of ␤TC 3 cells to calcitriol altered the expression of the survival factors (IGF-I and IGF-II).
Materials and Methods

Cell lines and cultures
␤TC 3 were originally provided by Shimon Efrat (Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel). ␤TC 3 , ␤TCtet, and ␤TCtet/bcl2 were grown in RPMI 1640 supplemented with 10% fetal calf serum, 2 mm l-glutamine, and 100 IU/ml streptomycin/penicillin. ␤TC p53 ϩ/ϩ and ␤TC p53 Ϫ/Ϫ were cultured in DMEM supplemented with 20% fetal calf serum, 2 mm glutamine, and 100 IU/ml streptomycin/ penicillin. Cultures were performed under standard humidified conditions of 5% CO 2 and 95% air at 37 C.
Western blot analysis
␤⌻C 3 cells were seeded at a density of 2 ϫ 10 6 onto 10-cm 2 tissue culture plates and allowed to attach and grow for 48 h. The medium was then replaced with fresh medium containing vehicle (ethanol; final concentration, 0.04%) or increasing calcitriol concentrations (10, 100, and 1000 nm). After 20 min and 4, 8, 24, and 48 h, cells were harvested and lysed in 200 l lysis buffer (30 mm Tris-HCl, 5 mm EGTA, 5 mm EDTA, 250 mm sucrose, 1% Triton X-100, 1 mm sodium fluoride, 2 mm sodium orthovanadate, 1 mm phenylmethylsulfonylfluoride, and 1 g/ml aprotinin). After 1 h at 4 C, lysates were centrifuged at 13,000 rpm for 5 min, and the extracted proteins were analyzed by Western blotting using the following antibodies: anti-p53 (rabbit antigoat; 1:100; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-p21 (rabbit antigoat; 1:100; Santa Cruz Biotechnology, Inc.), anti-NFB (p65, rabbit antigoat; 1:100; Santa Cruz Biotechnology, Inc.), anti-IB-␣ (goat antirabbit; 1:100; Santa Cruz Biotechnology, Inc.), and antiactin (goat antirabbit; 1:100; Sigma-Aldrich Corp., St. Louis, MO) commercial antibodies.
The levels of phosphorylated p53 protein were measured in ␤TC 3 cells after 20-min exposure to calcitriol (1000 nm) in the presence or absence of MEK inhibitor (Uo126, 2 nm) and PKC inhibitor (staurosporine, 5 nm). Extracted proteins were analyzed by immunoblotting with antisera against anti-phospo-p53 Ser 15 (rabbit polyclonal antibody; 1:1000; CELBIO, New England Biolabs, Inc., Beverly, MA). Western blot bands were quantitatively analyzed by scanning acquisition (ScanJet 5300C, Hewlett-Packard Co., Palo Alto, CA) and analyzed using Scion Image software (NIH).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
The number of viable cells was determined using the MTT method according to the manufacturer's recommendation (Sigma-Aldrich Corp. 
Relative quantitative RT-PCR
Calcitriol-induced expression of Bak and Bax genes in ␤TC 3 was determined using the Gene Specific Relative RT-PCR kit (Ambion, Inc., Austin, TX). The relative expressions of IGF-I and IGF-II were determined by RT-PCR using primers and amplification conditions previously described (20) . IGF-II primers amplify common sequences of 4.8 and 6.0 transcription isoforms and do not discriminate between the two isoforms.
Northern blot analysis
The expressions of IGF-I, IGF-II, and GADD45 genes were measured in ␤TC 3 cells cultured for 48 h in the presence of increasing concentrations of calcitriol (10, 100, and 1000 nm). Total cellular RNA was prepared with the RNAfast RNA isolation system (M-Medical, Firenze, Italy), and 20 g RNA from each sample were electrophoresed on 1% denaturing agarose gel. Blots were sequentially hybridized with a human IGF-I cDNA probe (a gift from Dr. Antonio Torsello, University of Milan, Milan, Italy), a rat IGF-II cDNA probe (provided by Dr. Steen Gammeltoft, Bispebjerg Hospital, Copenhagen, Denmark), a human GADD45 cDNA probe (provided by Dr. Michael O'Reilly, University of Rochester, Rochester, NY), and a 18S cDNA probe. Relative expression levels of IGF-I, IGF-II, GADD45, and 18S were determined by densitometric analyses.
Statistical analysis
In vitro studies consisted of a minimum of three independent experiments, each carried out at least in duplicate. Datasets were expressed as the mean Ϯ se. Statistical analysis was performed using the unpaired t test for pairwise comparisons or one/two-way ANOVA (Tukey post hoc test), as appropriate. Statistical significance was considered at P Ͻ 0.05.
Results
Genes differentially expressed by ␤TC 3 cells cultured in the presence of calcitriol
Gene array analysis was performed to identify genes differentially expressed upon treatment of ␤TC 3 cells with calcitriol. Exposure to 1000 nm calcitriol induced the differential expression of a number of genes; some are known to be functional in the regulation of the cell cycle and apoptosis, and some are survival factors, all consistent with calcitriol's antineoplastic effect on ␤TC 3 cells (Tables 1 and 2 ). Seven of the 588 genes tested were switched on/off by calcitriol, Values are the mean Ϯ SE; n ϭ 3 independent experiments; P Ͻ 0.05 for each gene listed in the table.
whereas nine of them were statistically up-or down-regulated. The proapoptotic genes Bak and Bax were up-regulated by 198% and 166% of control values, respectively. A modest, but significant, increase in the expression of p21 mRNA levels was also detected. Moreover, the expression of GADD45, undetectable in control ␤TC 3 , was induced by calcitriol. N-Cadherin was another gene with up-regulated expression upon calcitriol treatment. Conversely, calcitriol down-regulated the expression of G 2 /M-specific cyclin B2 and IGF-II genes to 50% and 80% of control values, respectively, whereas the only gene that was silenced by calcitriol was angiogenin. Down-regulation of this potent angiogenic factor may contribute to the antineoplastic activity of calcitriol observed during insulinoma development in RIP1Tag2 mice in vivo (8) .
Calcitriol increases p53 and phosphorylated (Ser 15 ) p53 protein levels in ␤TC 3
We have previously shown that the MAPK pathway is nongenomically activated by calcitriol in ␤TC 3 (8) . Because of the well established link between p53 signaling and the MAPK cascade (21), we investigated whether the p53 pathway was involved in the antineoplastic effect of calcitriol on insulinoma cells. After 48 h of culture in the presence of increasing calcitriol concentrations, whole cell lysates were collected, and p53 levels were assessed by Western blot. As shown in Fig. 1A , p53 protein doubled after exposure to 100 nm calcitriol. Increasing the calcitriol concentration to 1000 mm did not further increase p53 protein levels. At 10 nm, calcitriol induced only a modest, nonsignificant increase in p53 protein.
Calcitriol also induced an increase in the levels of p53 phosphorylated at Ser 15 to about 200% of control values by 20 min after treatment with 1000 mm calcitriol (Fig. 1B) . This effect was prevented by the PKC inhibitor staurosporine, but not by the MEK inhibitor Uo126 (Fig. 1B) .
␤TC p53 Ϫ/Ϫ cells are less susceptible to calcitriol-induced cytotoxicity
To further investigate the involvement of p53 in calcitriolinduced insulinoma cell death, we used p53-null ␤TC cells (␤TC p53 Ϫ/Ϫ ), which have been derived from tumors in RIP1Tag2/p53 Ϫ/Ϫ mice (22) . Forty-eight hours of culture in 1000 nm calcitriol induced a significant decrease in the number of viable control ␤TC p53 ϩ/ϩ , and ␤TC p53 Ϫ/Ϫ cells. A, Culture in presence of calcitriol induced a dose-dependent increase in p53 protein levels in ␤TC 3 cells. p53 increased, albeit not significantly, at 10 nM calcitriol and increased further at 100 nM calcitriol. At 100 nM calcitriol exerted its maximal effect (*, P Ͻ 0.05; #, P Ͻ 0.01 vs. control; n ϭ 3 experiments, each performed in triplicate). B, Calcitriol (1000 nM) induced an increase in p53 phosphorylation at the level of serine 15 after 20 min of exposure (*, P Ͻ 0.05; #, P Ͻ 0.01 vs. control; n ϭ 5 experiments, each performed in duplicate). Phosphorylation of p53 was efficaciously prevented by the PKC inhibitor staurosporine, but not by the MEK inhibitor Uo126. C, Forty-eight hours of calcitriol exposure decreased ␤TC 3 and ␤TC p53 ϩ/ϩ cell viability by about 30% and 40%, respectively. In contrast, in ␤TC p53 Ϫ/Ϫ cells calcitriol decreased cell viability only modestly (*, P Ͻ 0.05 vs. control; **, P Ͻ 0.05 vs. control and vs. ␤TC p53 ϩ/ϩ exposed to calcitriol; n ϭ 6 experiments, each performed 16 times). Data are the mean Ϯ SE; significance was determined by one-way ANOVA, post hoc Tukey test. citriol, exhibiting only a modest decrease in the number of viable cells (Fig. 1C) .
Calcitriol increases p21 protein levels in ␤TC 3
Antiproliferative signals, including serum deprivation or DNA damage, result in transcriptional activation of p21, a well known inhibitor of cyclin-dependent kinase (cdk2). p21, a bona fide transcriptional target gene of p53, was significantly up-regulated by calcitriol, as demonstrated by the gene array (Table 1) and Western blots (Fig. 2A) . Calcitriol increased p21 protein in ␤TC 3 cells in a dose-dependent manner to 160%, 180%, and 210% of control values after culture in 10, 100, and 1000 nm calcitriol, respectively ( Fig. 2A) .
Calcitriol increases NFB protein levels
It has been previously shown that induction of p53 causes an activation of NFB that correlates with the ability of p53 to induce apoptosis (23) . Therefore, we determined the protein levels of NFB in ␤TC 3 cells after 48 h of culture in the presence of increasing concentrations of calcitriol. NFB protein levels increased to 200% of control values at 10 nm calcitriol, a level that did not significantly change with higher concentrations of calcitriol (Fig. 2B) .
Time course of the expression levels of p53, NFB, IB, and p21 protein upon calcitriol exposure
The protein levels of p53, NFB, IB and p21 were measured 20 min and 4, 8, 24, and 48 h after exposure to 100 nm calcitriol and were compared with control levels. As shown in Fig. 3A , the increase in p53 protein levels was significant after 8 h and then remained stable for the entire period of stimulation. Conversely, NFB protein levels showed a biphasic pattern of activation with two peaks, at 8 and 48 h, that were separated by a decrease to control levels at 24 h. A similar biphasic pattern of NFB activation was recently reported (24) . Interestingly, IB protein levels showed the opposite pattern, with a decrease at 8 h (ϳ70% of control) and a peak at 24 h (ϳ200% of control; Fig. 3C ). Finally, p21 showed a significant increase in protein levels only after 48 h, suggesting that the transcriptional regulation exerted by calcitriol on this gene is exclusively mediated by its classical genomic effect (Fig. 3D ).
NFB inhibition with PDTC fails to protect ␤TC 3 cells from calcitriol-induced apoptosis
To test whether NFB activation was involved in calcitriolinduced apoptosis, treatment with calcitriol was performed in the presence or absence of PDTC (25, 26) , an inhibitor of NFB DNA-binding activity (Fig. 4A) . PDTC alone was toxic for ␤TC 3 cells at the lowest concentration known to have a biological effect (20 m). Moreover, when calcitriol and PDTC were added together, the number of viable cells decreased further, indicating an additive effect of calcitriol and PDTC on ␤TC 3 cells.
Calcitriol does not increase NFB protein levels in ␤TC p53
Ϫ/Ϫ cells
To better understand the relationship between p53 and NFB, we measured NFB protein levels in ␤TC p53 ϩ/ϩ and p53 Ϫ/Ϫ cells, which, as previously shown, are partially resistant to calcitriol-induced apoptosis. As shown in Fig. 4B, 8 and 48 h after calcitriol exposure, NFB protein levels were increased in ␤TC 3 and ␤TC p53 ϩ/ϩ cells, but not in p53 Ϫ/Ϫ cells.
Calcitriol increases GADD45 gene expression
DNA damage and environmental stress activate GADD45, a p53-regulated gene that is thought to play a role in growth arrest and cell death. Gene array analysis showed that calcitriol switched on GADD45 expression in ␤TC 3 cells (Table   FIG. 2. Effects of calcitriol on p21 and NFB protein levels. A, In ␤TC 3 cells, 48 h of exposure to increasing concentrations of calcitriol (10, 100, and 1000 nM) induced an increase in p21 protein levels, which were maximal already at 10 nM (*, P Ͻ 0.01; #, P Ͻ 0.05 vs. control, by one-way ANOVA, post hoc Tukey test; mean Ϯ SE; n ϭ 4 experiments, each performed in triplicate). B, In ␤TC 3 cells, calcitriol significantly increased NFB protein levels at the lowest concentration (10 nM) that was also maximally effective. After 48 h of culture, 10 and 100 nM calcitriol increased NFB protein to 215% and 250%, respectively (*, P Ͻ 0.02 vs. control, by one-way ANOVA, post hoc Tukey test; mean Ϯ SE; n ϭ 4 experiments, each performed in triplicate).
2). Even though a low level of expression of GADD 45 was detectable by Northern blot analysis, the inducible effect of calcitriol on GADD45 expression (Fig. 5) was confirmed. After 48 h of treatment, GADD45 mRNA increased to 206%, 236%, and 217% in the presence of 10, 100, and 1000 nm calcitriol.
Calcitriol up-regulates Bak and Bax gene expression in ␤TC 3 cells, whereas Bcl-2 overexpression completely prevents calcitriol-induced cytotoxicity
Gene array analysis revealed an increased expression of the proapoptotic genes Bax and Bak (Table 1) . We performed relative quantitative multiplex RT-PCR to confirm these results. We used two primer sets in a single PCR reaction: one set to amplify the cDNA of interest (Bak and Bax) and a second to amplify an invariant endogenous control (18S). These experiments revealed that after 48 h of culture in the presence of increasing calcitriol concentrations Bak and Bax expression were significantly increased in ␤TC 3 cells, with a maximal effect achieved at the lowest (10 nm) calcitriol concentration (Fig. 6, A and B) .
The ␤TC tet insulinoma cell line (27) was also sensitive to calcitriol-induced cytotoxicity; however, forced expression of Bcl-2 in ␤TC tet /Bcl-2 cells (28) completely abolished this effect (Fig. 6C) . These results suggest that calcitriol-induced apoptosis of tumor ␤-cells is modulated by members of the Bcl-2 family of genes.
Calcitriol induces IGF-I, but down-regulates IGF-II, gene expression
It has been shown that the IGF-I/IGF-II signaling pathway contributes to the antineoplastic effect of vitamin D in a variety of cancer cell lines (29 -31) . Therefore, we studied the expression of IGF-I and IGF-II by RT-PCR and Northern blotting in ␤TC 3 cells cultured for 48 h in the presence of increasing calcitriol concentrations. In ␤TC 3 cells, calcitriol induced the expression of IGF-I mRNA, which was completely silenced in control condition (Fig. 7, A and B) , an effect that was already evident at 10 nm. In contrast, calcitriol modestly, yet significantly, down-regulated the expression of two IGF-II mRNA isoforms (Fig. 7D) , thereby confirming the data obtained by RT-PCR (Fig. 7, A and C) .
Discussion
Besides its central role in the maintenance of calcium homeostasis and bone mineralization, calcitriol is an important modulator of cell growth and differentiation in a variety of cell types. We previously described a wide spectrum of negative effects exerted by calcitriol on mouse insulinoma ␤TC 3 cells, ranging from the induction of growth arrest and apoptosis of cultured tumor ␤-cell lines in vitro to the reduction of ␤-cell tumors in vivo in RIP1Tag2 transgenic mice (8) .
To learn more about the mechanisms responsible for the antineoplastic effects of calcitriol on insulinoma cells, we set out to identify genes that are differentially expressed by ␤TC 3 cells upon treatment with calcitriol. Calcitriol induced the differential expression of a number of genes known to be important in the regulation of the cell cycle. ␤TC 3 cells exposed to calcitriol exhibited a 50% decrease in the expression of the cyclin B2 gene, which is a central regulator of the progression from the G 2 phase to mitosis (32) . Another cell cycle gene differentially expressed by ␤TC 3 exposed to cal- , and 48 h of exposure to 100 nM calcitriol. A, p53 protein levels increased significantly after 8 h of stimulation and reached maximum levels after 24 h. B, NFB showed a biphasic pattern of induction, with a peak at 8 h, a decrease to control values at 24 h, and a second peak at 48 h. C, IB protein levels decreased at 8 h and increased thereafter, reaching a peak after 24 h. D, Finally, p21 protein levels increased at 24 and 48 h. The data are expressed as a percentage of the control and are the mean Ϯ SE of three independent experiments, each performed in duplicate (*, P Ͻ 0.05; **, P Ͻ 0.02; ***, P Ͻ 0.01 vs. control, by one-way ANOVA, post hoc Tukey test).
citriol was p21, whose mRNA expression was modestly, yet significantly, increased by calcitriol. Calcitriol-mediated expression of p21 was confirmed by Western blotting, revealing a dose-dependent increase in p21 protein in response to increasing calcitriol concentrations. Interestingly, timecourse experiments showed that p21 protein levels increased 24 h after calcitriol exposure, suggesting that this particular effect of calcitriol is mediated by the classic genomic pathway. p21 is an inhibitor of cdk and inhibits the formation of cyclin-cdk complexes necessary for transition from the G 1 to the S phase of the cell cycle (33) . Together, these findings are consistent with the previously reported growth inhibitory effect of calcitriol on ␤TC 3 cells, characterized by an increased number of ␤TC 3 cells found in the G 0 /G 1 fraction and a contemporary decrease in those in S and G 2 /M phases (8) .
p53 is the most important tumor suppressor protein identified to date and can influence the cell cycle in several ways.
It can cause growth arrest and apoptosis by forming complexes with other proteins, and it also acts as a transcription factor (34 -36) . Noteworthy, both cyclin B2 and p21 are transcriptional targets of p53 (33, 34) . Simian virus 40 large T antigen, a potent oncoprotein present in ␤TC 3 and ␤TC cells, exerts its oncogenic effect in part through binding to and inactivating the tumor suppressor gene products p53 and retinoblastoma (37) . In ␤TC 3 , calcitriol induced a 2-fold increase in p53 protein levels, an effect that was already maximal at 100 nm. Time-course experiments showed that at this concentration of calcitriol the increase in p53 protein levels was already evident after 8 h of stimulation, even though the maximal effect occurred at 48 h. It has been shown that in response to DNA damage, p53 protein levels and activity increase mainly as a result of its phosphorylation (35) , which can be induced by DNA damage-sensing kinases as well as by MAPKs (39, 40) . Therefore, we explored whether calcitriol would induce p53 phosphorylation in insulinoma ␤TC 3 cells. We decided to study phosphorylation at serine 15, because this site of phosphorylation prevents the interaction of p53 with Mdm2, a protein that can down-regulate p53 via ubiquitin-mediated proteolysis. After 20 min of calcitriol treatment, ␤TC 3 cells showed a 2-fold increase in phospho-p53 protein levels. This effect was prevented by staurosporine, but not by UO126, suggesting that MAPKs are not involved in this specific phosphorylation, whereas PKC may be an upstream activator of p53 kinases. Taken together, these data suggest that calcitriol, by increasing the p53 level and activity by combining nongenomic and genomic effects, may reduce the oncogenic potential of T antigen in ␤TC 3 and ␤TC insulinoma cells.
Previous reports indicated that ␤TC cell lines derived from tumors of RIP1Tag2/p53-null mice have an apoptotic incidence comparable with normal ␤TC lines and suggested that p53-independent apoptotic pathways are used in ␤TC cells (41, 22) . To learn more about the role of p53 in calcitriolinduced insulinoma cell death, we performed a set of experiments with ␤TC p53-null cells (␤TC p53 Ϫ/Ϫ ). In ␤TC p53
Ϫ/Ϫ cells, calcitriol induced only a modest decrease in the number of viable cells (ϳ10% reduction), significantly lower than that observed in control ␤TC p53 ϩ/ϩ cells (ϳ40% reduction). Therefore, in contrast to the majority of classic chemotherapeutic agents (22) , calcitriol needs a functional p53 to fully exert its antineoplastic activity in insulinoma cells. Similar results were observed in glioma cells (42) , but not in breast and colon cancer cells, where the antineoplastic effects of calcitriol and its analogs do not require the function of p53 (43, 44) .
The role of NFB in programmed cell death and cell cycle is still controversial. Reportedly, the proapoptotic or antiapoptotic effect of NFB depends on the different cell types and the external stimuli applied (45) . In the resting cell, NFB is sequestered in the cytoplasm linked to its inhibitor protein, IB. Upon activation, free NFB increases as a result of IB phosphorylation and degradation. Free NFB translocates to the nucleus, binds its consensus sequences, and regulates the transcription of a variety of genes. We show here that calcitriol induces in ␤TC 3 cells a biphasic increase in NFB protein, similar to what occurs in skeletal muscle cells (24) . The first peak was observed after 8 h of stimulation and was associated with a significant decrease in IB protein levels, which, as previously reported (45) , might be consequent to IB phosphorylation by MAPKs. Perhaps a similar series of events may occur in ␤TC3 cells, as calcitriol can induce activation of the MAPK pathway (8) . A second increase in NFB protein levels was detected at 48 h and was associated with a decrease in IB.
It has been previously reported that induction of p53 causes an activation of NFB, which correlates with the ability of p53 to induce apoptosis (23) . To exclude such possibility, we studied the pattern of NFB activation in ␤TC p53 Ϫ/Ϫ cells and the effect of NFB inhibition with PDTC. As shown in Fig. 4B , calcitriol-induced increase in NFB was completely absent in ␤TC p53 Ϫ/Ϫ cells at both 8 and 48 h. Moreover, as shown in other cell lines (46, 47) , inhibition of NFB decreased ␤TC 3 cell viability and amplified calcitriolinduced cytotoxicity. Taken together these data suggest that NFB up-regulation is an antiapoptotic reaction mounted by these cells against calcitriol-induced cell death.
As previously reported in glioma cells (42) , calcitriol upregulated the expression of GADD45, another important p53-dependent regulator of cell fate (48) , in ␤TC 3 cells.
Calcitriol also increased the expression of Bak and Bax, two proapoptotic members of the Bcl-2 gene family (49). This effect is consistent with the reported capability of p53 to transcriptionally activate Bax (50) . The involvement of proapoptotic Bak and Bax may contribute to calcitriolinduced ␤TC 3 cell death by causing mitochondrial membrane damage. Overexpression of the antiapoptotic Bcl-2 gene completely prevented calcitriol-induced apoptosis. Hence, although multiple pathways may be involved in calcitriol-induced ␤TC 3 cell apoptosis, they can be modulated by the function of Bcl-2, which is known to play a pivotal role in the regulation of cell death by acting at the mitochondrial and pre-and postmitochondrial levels (51) . It is noteworthy that Bcl-2 overexpression in breast cancer cells conferred complete protection against apoptosis induced by vitamin D compounds, which in these cells is a p53-independent event (43) .
IGF-I and IGF-II are the most abundant growth factors in the body and act as potent survival factors. Exposure of ␤TC 3 to calcitriol induced the expression of IGF-I mRNA, that is undetectable in control cells, as shown by RT-PCR and Northern blotting. The induction of IGF-I expression was associated with a modest, but significant, downregulation of the IGF-II gene in both its isoforms. Calcitriolmediated IGF-II down-regulation is consistent with its antineoplastic effects. Similar results have been reported in prostate cancer cells, where vitamin D-mediated growth inhibition was associated with increased levels of IGFbinding protein-3 mRNA (52, 53) . Calcitriol-induced IGF-II down-regulation may be particularly relevant in vivo in the prevention of insulinomas in transgenic RIP1Tag2 mice. In these mice, which represent a well characterized model of multistage ␤-cell tumorigenesis, all the islets of Langerhans express simian virus 40 T antigen, yet only half of them become hyperplastic, and only a minority of these eventually progress to solid ␤-cell tumors (9, 54) . Notably, in these mice the onset of proliferation strictly correlates with the expression of IGF-II in the ␤-cells (55) . Perhaps, a precocious treatment of RIP1Tag2 mice with calcitriol may prevent this proliferative switch and thus the development of ␤-cell tumors.
Calcitriol-induced IGF-I expression is less compatible with the antineoplastic effect of calcitriol on ␤TC 3 cells. Nevertheless, calcitriol-induced IGF-I up-regulation in pancreatic ␤-cells is particularly appealing and may be relevant to the reported beneficial effect of calcitriol on the pathogenesis of type 1 diabetes. It has been shown that treatment with calcitriol prevents diabetes in the NOD mouse (56) as well as the recurrence of autoimmune destruction of syngeneic islet grafts (57) . These effects have been related to the known immunomodulatory properties of vitamin D 3 on dendritic cells (58) . However, our observation that calcitriol induces IGF-I up-regulation in tumor ␤-cells and the recent finding that ␤-cell-targeted IGF-I overexpression counteracts insulitis-associated type 1 diabetes (59) suggest that calcitriol might exert its antidiabetic effect also by decreasing ␤-cell susceptibility to proinflammatory cytokines via IGF-I up-regulation.
In conclusion, calcitriol exerts a profound antineoplastic effect on mouse insulinoma cells, which is mediated by the abnormal expression of a series of genes involved in the control of cell cycle and cell death. The antineoplastic effect of calcitriol on insulinoma cells appears to depend mainly on the p53 pathway and to involve both the genomic and nongenomic pathways. These data support the rationale for testing calcitriol or its lower calcemic analogs in the treatment of patients with malignant insulinomas and possibly other p53 function-retaining endocrine tumors. Moreover, calcitriol-induced IGF-I overexpression, if confirmed to occur also in normal ␤-cells, may provide an additional rationale for using vitamin D compounds in the prevention of autoimmune diabetes and to promote the engraftment and survival of pancreatic islet allografts.
